EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pomegranate Juice Alleviates Preeclampsia Symptoms in an L-NAME-Induced Rat Model: A Dose-Dependent Study

Sasitorn Kerdsuknirund iD, Atcharaporn Thaeomor, Pakanit Kupittayanant, Panida Khunkaewla, Suthida Chanlun, Rungrudee Srisawat, Pattama Tongdee, Porntip Nimkuntod, Sajeera Kupittayanant

Nutrients · 2025

DOI: 10.3390/nu17071143 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2025. Verfasst von Sasitorn Kerdsuknirund und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Preclinical Sciences, Institute of Science, Suranaree University of Technology, Nakhon Ratchasima 30000, Thailand. Hauptthemen laut MEDLINE: Pre-Eclampsia, Fruit and Vegetable Juices, Pomegranate. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This research was supported by Suranaree University of Technology (SUT), Thailand Science Re-search and Innovation (TSRI), and National Science, Research and I…, Suranaree University of Technology (SUT).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study aimed to evaluate the dose-dependent therapeutic effects of pomegranate juice on preeclampsia symptoms using an L-NAME-induced rat model.

Methods

Pregnant rats (n = 5/group) were assigned to a negative control group or groups receiving L-NAME to induce preeclampsia, with pomegranate juice administered at low, medium, and high doses from gestation day 7 to 20. Maternal parameters, including body weight, systolic blood pressure, urinary protein, and sFlt-1 levels, were monitored. Kidney and placental histology were assessed on gestation day 20.

Results

L-NAME successfully induced preeclampsia symptoms, including significant maternal weight gain, hypertension, proteinuria, and increased sFlt-1 levels. Pomegranate juice administration alleviated these symptoms in a dose-dependent manner. High doses significantly prevented weight gain from gestation day 14, reduced the systolic blood pressure from gestation day 16, and lowered proteinuria and the sFlt-1 levels by gestation day 18, achieving values comparable to those of normal pregnant controls. Medium doses showed a moderate improvement, particularly in later gestational stages, while low doses had minimal effects. Pomegranate juice also enhanced placental health by increasing the labyrinth depth and reducing endocapillary hypercellularity, contributing to higher fetal and placental birth weights. The dose–response analysis indicated that the kidneys exhibited a stronger response to pomegranate juice than the placenta, suggesting different sensitivity thresholds.

Conclusions

Pomegranate juice alleviates preeclampsia symptoms in a dose-dependent manner, significantly improving maternal weight regulation, blood pressure, and proteinuria. The therapeutic effects of pomegranate juice are attributed to its high phenolic content, which reduces sFlt-1 and improves placental function. These findings support pomegranate juice as a potential natural intervention for preeclampsia management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pre-EclampsiaFruit and Vegetable JuicesPomegranateAnimalsFemalePregnancyNG-Nitroarginine Methyl EsterDisease Models, AnimalRatsBlood PressurePlacentaRats, Sprague-DawleyVascular Endothelial Growth Factor Receptor-1Dose-Response Relationship, DrugProteinuriaKidney

Stichwörter der Autor:innen

hypertensionplacentapomegranate juicepreeclampsiaproteinuria

Substanzen

NG-Nitroarginine Methyl EsterVascular Endothelial Growth Factor Receptor-1Flt1 protein, rat

Autor:innen und Institutionen

  • School of Preclinical Sciences, Institute of Science, Suranaree University of Technology, Nakhon Ratchasima 30000, Thailand.
  • School of Animal Technology and Innovation, Institute of Agricultural Technology, Suranaree University of Technology, Nakhon Ratchasima 30000, Thailand.
  • Biochemistry-Electrochemistry Research Unit, School of Chemistry, Institute of Science, Suranaree University of Technology, Nakhon Ratchasima 30000, Thailand.
  • Department of Pathobiology, Faculty of Veterinary Medicine, Khon Kaen University, Khon Kaen 40000, Thailand.
  • School of Obstetrics and Gynecology, Institute of Medicine, Suranaree University of Technology, Nakhon Ratchasima 30000, Thailand.
  • Suranaree University of Technology Hospital, Nakhon Ratchasima 30000, Thailand.

ORCID-Profile: Sasitorn Kerdsuknirund

Förderung

  • This research was supported by Suranaree University of Technology (SUT), Thailand Science Re-search and Innovation (TSRI), and National Science, Research and I…
  • Suranaree University of Technology (SUT)

Zitieren

APA

Kerdsuknirund, S., Thaeomor, A., Kupittayanant, P., Khunkaewla, P., Chanlun, S., Srisawat, R., Tongdee, P., Nimkuntod, P., & Kupittayanant, S. (2025). Pomegranate Juice Alleviates Preeclampsia Symptoms in an L-NAME-Induced Rat Model: A Dose-Dependent Study. Nutrients. https://doi.org/10.3390/nu17071143

Vancouver

Kerdsuknirund S, Thaeomor A, Kupittayanant P, Khunkaewla P, Chanlun S, Srisawat R, et al. Pomegranate Juice Alleviates Preeclampsia Symptoms in an L-NAME-Induced Rat Model: A Dose-Dependent Study. Nutrients. 2025. doi:10.3390/nu17071143

BibTeX
@article{Kerdsuknirund2025,
  author = {Kerdsuknirund, Sasitorn and Thaeomor, Atcharaporn and Kupittayanant, Pakanit and Khunkaewla, Panida and Chanlun, Suthida and Srisawat, Rungrudee and Tongdee, Pattama and Nimkuntod, Porntip and Kupittayanant, Sajeera},
  title = {Pomegranate Juice Alleviates Preeclampsia Symptoms in an L-NAME-Induced Rat Model: A Dose-Dependent Study},
  journal = {Nutrients},
  year = {2025},
  doi = {10.3390/nu17071143}
}
Kostenlos starten →